STAT3 as a target in H3K27M-mutant diffuse midline gliomas
A new editorial perspective was published in Oncotarget, titled "STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma."
Oct 10, 2023
0
1
A new editorial perspective was published in Oncotarget, titled "STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma."
Oct 10, 2023
0
1
A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology" has been published in Oncotarget.
Oct 5, 2023
0
6
A team of researchers at the Medical University of Vienna has discovered that dormant tumor cells surviving chemotherapy can be targeted through the inhibition of a specific protein called P-glycoprotein (P-gp). This discovery ...
Oct 2, 2023
0
6
A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk multiple myeloma, according ...
Sep 22, 2023
0
51
Small cell lung cancer accounts for about 15% of all diagnosed lung cancers and is still associated with a high mortality rate. SCLC tumors often develop resistance to chemotherapy and thus poor prognosis is due to tumor ...
Sep 21, 2023
0
0
Regular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome (LS) by improving the immune system's ability to detect and remove potentially harmful cells, according to researchers ...
Sep 19, 2023
0
50
Researchers at the University of Chicago Medicine Comprehensive Cancer Center established "proof-of-concept" for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The ...
Sep 18, 2023
0
8
After being told they are at high risk from genetic test results that do not take family history into account, women could be opting to have unnecessary surgery to avoid breast cancer.
Sep 14, 2023
1
85
A new editorial paper titled "Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?" has been published in Oncotarget.
Sep 13, 2023
0
1
A new editorial paper titled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published in Oncotarget.
Sep 11, 2023
0
13